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INTRODUCTION
· Rising costs ~ave changed man·• s ideals and eating habits.

Plant

ingredients , bec ause of their relatively low costs, have been
increasingly used as a substitute for animal proteins.

If these

plant ingredients could be directly utilized by man, this would be a
more efficient use of energy and nutrients.

One plant source

currently used i n such a manner is soybeans, which is a prime source
of protein for human and livestock nutrition.

However, soybeans

contain several factors that are detrimental to man and livestock.
Heating of. soybeans ~ounteracts these factors, since the undesirable
factors are heat labile.

However, heat alters the protein's

properties making t hem unsuitable for many food products and calf
milk replacers .

Consequently, soybean processors currently use little

or no heat in the production of soybean "isolates" and "concentrates."
In their process, they discard, as waste, the soybean whey fraction.
This fraction contains the toxic factors, but also usable protein and
carbohydrate material. · Such a practice wastes 20% of the soybean
protein in addition to adding to today's ever pressing pollution
problem.
The purpose of this research project was to further isolate
and purify a small molecular weight growth inhibitor from soybeans
and to gain needed knowledge about its properties.

(

Once this growth

2

inhibitor is identified, appropriate methods of inactivating or
removtng the inhibitor may be developed, .so that much, if not all
of the soybean whey proteins may be used beneficially for mankind.
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LITERATURE REVIEW

More than 50 yea:rs have: passed since Osborne and Mendel (47)
.reported the improved growth-promoting property of cooked versus raw
soybeans.

The explanation for this fact still remains unclear.

Numerous studies and improved technology have only increased the
complexity of the problem.

Many factors have been implicated as the

cause for the growth inhibition associated with raw soybeans, and
these will be discussed in the following pages.
Trypsin inhibitors.

The finding (22) of a trypsin inhibitor

in soybeans appeared -to explain the cause of the growth depression
found when feeding raw soybeans.

Westfall et al. (64) further

substantiated this finding, when they found that the activity of this
inhibitor was destroyed by autoclaving.

This concept was supported

when a crude trypsin inhibitor preparation was added to a heated
soybean ration and reduced growth rates in chicks (23) and rats (30)
resulted.

Because of these results, trypsin inhibitors have received

the majority of the attention in investigations designed to find the
cause of growth depression by raw soybeans.
Kunitz (31) first isolated a crystalline globulin protein from
raw soybeans which forms, instantaneously, an irreversible
stoichiometric compound with trypsin (20, 35, 57).

When this trypsin

inhibitor is denatured, it can be readily digested by pepsin (32).
Even the undenatured form is slowly digested by pepsin (28).

nine trypsin inhibitors have been isolated from soybeans (4o).

To date
These
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inhibitors vary in size from 8,000 (16) to 24,000 molecular weight (32)
and in other physical and chemical properties.

Commercially available

soybean trypsin inhibitors are usually the Kunitz inhibitor (31).
· Crystalline soybean trypsin inhibitor, when added to
chick (17, 19) and rat (19, 21) diets, depressed growth but never to
the extent found when raw soybean meal (RSBM) was fed.

When the soy-

bean whey fraction· was separated into two fractions, one fraction
high in trypsin inhibitor activity and the other high in
1hemagglutinating activity, · the ~ombination of the two fractions
inhibited chick growth rates to a greater extent than either fraction
alone (17).

The soybean whey fraction contains trypsin inhibitors,

hemagglutinins and unidentified components (14, 50, 51).

Adding a

potent trypsin inhibitor, p-aminobenzamidine, to the drinking water
of rats caused growth depression, but reduced feed intake probably
caused most of the growth depression (18).
Borchers and Ackerson (9) and Brambila (10) proposed that the
depressed growth assessed to trypsin inhibitors could be compensated
by adding trypsin to the ration and thus tie up the soybean trypsin
inhibitors with exogenous trypsin.

However, the addition of trypsin

to RSBM diets fed to rats (9) and chicks (10) could not overcome the
growth-depressing effect of RSBM.
Another approach was based on the hypothesis that if feeding
RSBM caused interference of the enzymatic digestion in the small
intestine and therefore caused growth depression, supplementing amino
\

'-..__/
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acids should correct the growth depression (44).

Some researchers

(2, 7, 8, 9) felt they could raise the biological value of raw soybeans by supplementing the sulfur-containing amino acids instead of
feeding intact proteins.

This appeared to be a reasonable assumption

because soybeans are low in methionine (59), while trypsin contains
a relatively high level of cystine (3) which is usually synthesized
from methionine.

However, methionine supplementation of RSBM diets

never produced growth rates equal to those achieved on autoclaved
soybean meal diets (3, 8).

Additional support for these results can

be gathered from the research (24) that the supplementation of~

RSBM diet with=11 amino acids required by chicks did not improve
growth rates.

Replacement of the RSBM by heated soybean meal

resulted in substantially increased weight gains.

Borchers (7) first

found that supplementation of amino acids could alleviate the growth
depression found when RSBM was fed, but later concluded that amino
acid supplementation could produce only 75% the growth rate of the
rats fed heated soybean meal diets (8).

The addition of amino acids

to the diet should have compensated for all the growth depression if
trypsin inhibitors were the sole cause of growth depression.
The ability of the animal to secrete extra enzymes as
compensation for trypsin inhibitors in the diet (56) also indicates
that trypsin inhibition was not the growth depressant.

Even with 95%

of the pancreas removed, there was no reduction in nitrogen digestion
and absorption in rats as measured by fecal excretion (56).

Protein

digestion was only reduced when 99.5% of the pancreas was removed.

6

Schi ngoe t he et al. (54), using a Sephadex G-50 column,
separated a small molecular weight gtowth inhibitor from trypsin
inhibitors.

Hal f of the growth inhibition attributed to the soybean

whey fraction was caused by the small molecular inhibitor, but caused
no pancreas enlargement.
Finall y, germinated soybeans had a protein efficiency ratio
almost equal t o tnat of heated meal (15), but much higher than raw
soybeans.

The higher protein efficiency value with germinated

: soybeans occurred even though there was no reduction in trypsin
inhibitor concentration (13).
Hemaggluti nins.

Besides the antitryptic factor, hemagglutinins

in raw soybeans have been incriminated as the growth depression

factor.

Hema gglutinating agents have been known to be present in

plants since the 1880's (39).

Hemagglutinin extracts from different

seeds agglut inate t he red blood cells from some species of animals
but not the cel ls from other species (4, 34, 42).

Liener and co-

workers (41) had diffi~ulty correlating growth inhibition and
trypsin inhibitor ac t ivity when feeding a diet containing a protein
hydrolysate along with an antitryptic factor.

They suggested the

presence of some substance other than the antitryptic factor which
adversely affects growth.

Further investigation by Liener and

Pallansch (42) resulted in the isolation of a homogeneous protein
high in hemagglutinin activity.

Additional purification indicated

it had a molecular weight of 96,000 and contained 6-10%
glucosamine ( 61) •

_ /
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Evidence that the hemagglutinins may be responsible for the
growt~-inhibiting properties of soyqeans has been minimal.
Intraperitoneal injections of hemagglutinin preparations were lethal
to young rats (37).

However, physiologically this information is

questionable because hemagglutinins are readily inactivated by peptic
digestion when as few as 12% of the peptide bonds are split (38, 6).
This should result in complete or almost complete inactivation prior
to entering the small intestine.

Also it is unlikely that an intact

/ protein of 96,000 molecular weight, even if it survived gastric
digestion, could be absorbed from the gut.

Wada et al. (61) found

that as they i"ncreased the hemagglutinin activity during the
purification procedure there was only a slight increase in toxicity.
When the hemagglutinin-containing fraction of soybean whey was
separated from trypsin inhibitors and small molecular weight growth
inhibitors by ion exclusion chromatography, very little growth
inhibitor activity was found in the hemagglutinin fraction (54).
Saponins.
plants.

Sapoµins are glycosides which occur in a variety of

They are characterized by bitter taste, foaming in aqueous

solutions and hemolyzing red blood cells.
they yield sapogenins and sugars.

Upon complete hydrolysis

Proteolytic activity of trypsin

was inhibited by high levels of soybean saponin (26).
Since saponins interfered with proteolytic activity and caused
· hemolysis of red blood cells, it was quite possible that saponins
were the cause of the poor nutritive value of RSBM.

Birk et al. (5)

found that heat treatment had no effect on the hemolytic activity of

8
saponins.

Since heat treatment of soybean m~al alleviates the growth

depression, saponins ,must not be the ·growth-depressing factor.

The

.antiproteolytic activity was caused from a nonspecific reaction of
saponins with protein an~ was readily counteracted by the presence of
dietary proteins (26).
Pancreatic enlargement.

Feeding RSBM diets cause growth

depression along with pancreas enlargement in chicks (11, 46, 53),
rats (43, 48) and mice (54).

Chernick et al. (11) found that chicks

fed a RSBM diet had enlarged pancreases and suggested this was
caused by the increased demand for trypsin which was met by increased
secretion by the pancreas.

The overall concentration of the

proteolytic enzymes in. the pancreases of the chicks fed raw soybeans
was unchanged, but with increased size of the organ the total activity
was increased.

This increase in size of pancreases has been attributed to
levels of fat in diet (45), a factor in soybean hulls (58) and also
trypsin inhibitors (43; 49).

The pancreas enlargement produced by

feeding raw soybeans has been suggested to be associated with growth
depression, but there is no definite proof of the cause and effect.
Kakade and co-workers (27) tested 104 varieties of soybeans and found
a negative correlation (r = -.77) between pancreas size and protein
efficiency ration when feeding raw soybean diets to rats.
Schingoethe and Thomas (55), when feeding rats diets containing
soybean trypsin inhibitors, found growth depression with only two of
the four diets although all four diets caused pancreas enlargement.

9

The addition of soybean hulls to a purified ration caused pancreas
enlar~ement with no growth depression. (58).

Also, a growth inhibitor

has been separated from soybeans that did not cause pancreas
enlargement (54).

wss of endogenous nitrogen.

Because of increased enzyme

production in animals fed a raw soybean diet, Lyman and Lepkovsky

(43) felt that this could result in a large loss of endogenous
nitrogen.

The loss of nitrogen via this route could possibly account

for some of the growth depression attributed to raw soybeans.

This

suggestion was further s~bstantiated when rats fed heated meal had
lower proteolytic activity in their feces than rats fed unheated
meal (36).

Other researchers (12, 21, 29, 55) found increased

proteolytic activity and increased trichloroacetic acid-insoluble
protein in the intestinal contents of rats fed RSBM or diets
containing soybean trypsin inhibitors.
However, Kwong et al. (33) doubt whether this endogenous loss
of nitrogen accounts for the growth depression found when feeding raw
soybeans.

They found no decrease in the percentage of nitrogen

absorbed in rats fed a diet of unheated flakes starting at 25% and
increasing to 75% of the total diet.

Others (55) observed that

despite the increased intestinal proteolysis on four trypsin inhibitorcontaining diets, rat growth rates were reduced on only two of the
diets.
Amino acid deficiency.

Little agreement is found as to the

extent amino acid supplementation will improve the nutritive value
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of RSBM diets.

Adding methionine to a RSBM diet did not completely

compensate for the growth depression .(2, _8).

Borchers (7) claimed

that adding methionine to a RSBM diet could completely counteract the
'growt~ depression.

However, the weight gains (4.0 g/day) of these rats

were much less than gains (6.5 g/day) of rats fed by Barnes et al. (2).
They found that added methionine could account for only 75% of the
growth depression attributed to RSBM.

The differences in growth, rates

could be attributed to the protein levels in the diets.

Borchers fed

a low protein diet (15%) compared to the diets (20% to 35% protein)
fed by Barnes et al. (2).

The lower protein diets may have been

deficient in ~ethionine, and the added methionine would show more
response in the lower protein diet.

In later studies, Borchers (8)

could attain only 75% of the growth of rats fed the heated soybean
diet.

Barnes et al. (2) suggested that supplemental methionine would

increase growth rates of rats receiving low levels of heated or
.

unheated soybean preparations because methionine is the most limiting
amino acid in soybeans.

However, high levels of heated soybean meal

provided the needed methionine and supplemental methionine showed no
increased response.
Supplementation of eight amino acids to a RSBM diet equaled
the growth rate of the,heated soybean meal diet (7).

Again, because

of the lower protein content in the diet, the growth rates were not
as high as those attained by the rats fed by Barnes et al. (2).
However, there is no agreement among different investigators as to
whether the addition of amino acids would make the protein present
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in raw soybean meal equivalent biologically to that of heated meal,
or simply substitute for the protein~s deficiencies.
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MATERIALS AND METHODS
Preparation of soybean meal fractions.

Raw soybean meal

(RSBM) was prepared by grinding and hexane-extracting soybeans (Corsey
variety) as previously described by Schingoethe et al. (54).
Heated raw soybean meal (HRSBM) was prepared by autoclaving raw
meal according to procedures outlined by Renner and Hill (52).

This

procedure was modified slightly, in that the meal was autoclaved at
110 C (15 lb steam pressure) for 15 minutes.

After autoclaving the

meal, it was air dried at room temperature and finely ground.
One hundred grams of RSBM was extracted with one liter of
distilled water for two hours at room temperature.

During the

extraction, the RSBM was slowly agitated with a magnetic stirr~r and
then centrifuged (5,000 revolutions per minute for 10 minutes) to
remove the water insoluble portion.

After pouring off the supernatant,

the meal was re-extracted with 500 ml of distilled water for one hour
and centrifuged.

The resulting supernatants were combined, acidified

to pH 4.4 with 6N HCl (remove the acid insoluble proteins) and
centrifuged.

1
After lyophilizing , the pH 4.4 supernatant (pH 4.4-S)

was stored for later use.
Ion exclusion chromatography.

Ion exclusion chromatography was

employed in an attemp~ to further purify and separate the growth
inhibitor (s).

Experimentation with Sephadex G-25, G-15 and G-10

1Virtis Research Equipment, New York.
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columns indicated that the G-25 column gave the most desirable
separation.

With an exclusion limit . of 5,000 molecular weight (MW)

for proteins _, the trypsin inhibitors of 8,000 MW (16) to 24,000 MW
(31) and hemagglutinins of 96,000
would elute with the void volume.

MW

(61) would not be retarded, and

The growth inhibitor (s) isolated

by Schingoethe et al. (54) would be slightly retarded.

Lyophilized.pH 4.4-S (2.25g) was redissolved in 75 ml of
distilled water and applied to the Sephadex G-25 column (5.7 x 107 cm),
,i' which was moni tared by a record.ing spectrophotometer at 280 nm.
pH 4.4-S was eluted with distilled water at 23 ml/minute.

The

The effluent

was collected :in 23 ml aliquots and every other tube assayed for
trypsin inhibitor activity (25), protein (62, 63) and carbohydrate
concentration (1).

Approximately 20 runs were required to recover

enough material for one mouse growth assay.
Charcoal fractionation.

Figure 1 shows the fractionation scheme

that was employed using activated charcoal.

1

The pH 4.4-S was used as

the starting material and mixed thoroughly with the activated charcoal
prior to filtering.

The resulting filtrate (char filtrate) was saved.

The charcoal and adsorbed material was then washed with pH 11.5 NaOH,
pH . 8.0 NaOH and pH 2.5 HCl and each of the resulting filtrates were
saved.

Volumes of filtrates were approximately equal to the amount of

liquid that was used to wash the charcoal.

Samples were taken from

1
Mallinckrodt Chemical Works, St. Louis, Missouri.

27428
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CHARCOAL FRACTIONATION

pH 4.4·-S

1.2 L
CHAR FILTRATE

RESIDUE on CHARCOAL
1 L pH 11.5
(0.3N NaOH)

pH 11.5 FILTRATE

RESIDUE on CHARCOAL

_________
pH 8.0 FILTRATE

1L

pH 8.0
____....._
(0-15N NaOH) -

RESIDUE on CHARCOAL
1 L . pH 2.5

~---------_____.---(02N

pH 2.5 FILTRATE

HCL)

CH ARCOAL DISCARDED ·

Figure 1. Fractionation of the pH 4.4 supernatant using activated
charcoal as a crude ion exchange bed.
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each of the filtrates and analyzed for trypsin inhibitor activity (25),
protein (62, 63) and carbohydrate concentration (1) prior to
lyophilizing.

The pH 11.5 filtrate was the only filtrate neutralized

to pH 7.0 with 6N HCl.
Growth assay procedure.
table 1.

The test diet composition is shown in

The soybean meal was HRSBM except for the RSBM and Y2HRSBM-

1/2RSBM diets, in which case RSBM replaced HRSBM and served as negative
control diets.

Part of the HRSBM was replaced in the diet by one of

the various test fractions.

The test fractions were added to the

diets in amounts equivalent to the quantity recovered from 100 g of
RSBM.

To adjust for the loss incurred during fractionation, two times

this amount was added to the various diets.
Weanling mice were used as the test animal since Schingoethe
et al. (54) found that mice gave a similar response to that of weanling
rats but required less feed.

Dietary treatment differences were

observed at three days during the assay period, but most assays were
run for five days.

Tw~nty-one day old male mice were randomly

assigned to the various diets and divided into subgroups.

Usually

eight to ten mice were used per ' treatment with four to five mice in
each wire meshed cage.
were recorded.

Beginning, three-day and terminating weights

On th~ fifth day the mice were sacrificed and

pancreases removed and weighed.

Feed intake for each treatment

subgroup was determined by weighing the feed fed along with estimating
feed in the feeders at termination of the experiment.

A positive

16

Table 1.

Composition of Diets Fed to Mice

Ingredient
Salt mix

1

Amount
g

4.o

. mix
. 2
V1.·t am1.n

2.2

Corn oil

5.0

a - Cellulose 3

1.5

Glucose

4

37.3
50-X

.
6
Soybean meal test fraction

X

100.0

1wesson modification of Osborne-Mendel Formula,

Nutritional Biochemicals Corporation, Cleveland,
Ohio.
2vitamin diet fortification mixture, Nutritional
Biochemicals Corporation, Cleveland, Ohio.
3Nutritional Biochemicals Corporation, Cleveland,
ohio.
4
Dextrose, J. T. Baker Chemical Corporation,
Phillipsburg, New Jersey.
5 soybean meal is HRSBM in all cases except for
raw soybean meal fraction.
6Soybean meal fractions replaced part of the
HRSBM.
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control (HRSBM) along with two negative controls (RSBM or YiliRSBM1/2.RSBM .and pH 4.4-S) were fed during each ·mouse growth assay to serve
as controls tor that particular trial.
Growth inhibitor (GI) activity was calculated by the following
formulas as prepared by Schingoethe et al. (54):
1)

Total GI activity (units)=

(wt gain HRSBM - wt gain test) (feed intake test)

- - - - - , - - - - - - - - - . - - - - - - - - - - - - X 100

(wt gain HRSBM) (feed intake HRSBM)

; 2)

Specific GI activity (units/g) =

(wt gain HRSBM - wt gain test)
1
100 X - - - - - - , . - - - - - - - - - . - - - X - - - - - - - - - X

(wt gain HRSBM)

(feed intake HRSBM)

·1

(xg test)

One unit of GI activity equals 1% reduction in growth rate compared t o
the positive control.

Specific GI activity takes into account the

amount of test fraction in the diet.

Differences in feed intake were

negligible except for the RSBM, Y2HRSBM-Y2RSBM and pH 4.4-S diets
(Appendix tables 1-7).
Enzyme inhibito+ assay.

Trypsin inhibitor activities of soybean

meal and various fractions were determined by the measurement of the
inhibition of hydrolysis of p-toluenesulfonyl-L-arginine methyl ester
(TAME) 1 by trypsin (25).

The inhibitor samples were diluted to insure

that the assay mixture was not saturated by inhibitor.
Carbohydrate concentration determination.

Carbohydrate

concentration was determined as outlined by Badin et al. (1) at 520 nm.
1

Nutritional Biochemicals Corporation, Cleveland, Ohio.
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Statistical analysis.

The data from the various mouse growth

assays were analyzed individually according to the procedures by
Steele and Torrie (60).

The statistical significance between the

means was analyzed by Duncan's new multiple range test (60).
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RESULTS AND DISCUSSION
S'eparation on ,Sephadex G-25 column.

Figure 2 illustrates the

elution pattern of the pH 4.4-S on th~ Sephadex G-25 column.

Protein

values were calculated by the methods of Waddell (62) and Warburg and
Christian (63).

Since absorbencies at 280 run are proportional to

protein concentration, for expediency, the column runs were monitored
at this reading.

On the basis of protein determinations, the effluent

was divided into five fractions and designated as fractions I, II,
I

,' III, IV and V, respectively.
Fraction I (Fig. 2) contained all of the trypsin inhibitors.
Hemagglutinins were assumed to be present in fraction I (61), although
hemagglutinin assays were not conducted.

Chymotrypsin inhibitors

presumably were also located in this fraction (54), since most trypsin
inhibitors also inhibit chymotrypsin.

However, the fractions were not

analyzed for chymotrypsin inhibitor activity.

Carbohydrates were

eluted in the same area of fractions II and III (Fig. 2) and, thus,
were not separated from proteins or with one distinct protein fraction
by this method.

Small molecular weight material was located in

fractions IV and V (Fig. 2).
Growth inhibitor assay results of feeding the various pH 4.4-S
,

fractions separated on the Sephadex G-25 column are shown in table 2.
Weight gains (g/day) of mice fed fractions I and II were significantly
different from the HRSBM diet (P<0.05), but were not significantly
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Table 2.

Growth inhibitor assay of fractions of pH 4.4 supernatant
separated on Sephadex G-25 column •.

~est fraction

1

o.82a, 3

HRSBM
4
1/2RSBM

y'£RSBM

I

Pancreas
size
(% bw)

Weight
gain
(g/day)

-0.24

d

2
Growth Inhibitor
TA
SA
( uni ts/g)
(units)

0.69c
1.01a

130

97

pH 4.4 - s5

0.19c

o.95ab

77

145

G-25-r6

o.42bc

o.95ab

50

860

0.77b

63

_190

o.79ab

o.6oc

4

·3 0

o.84a

o.64c

0.87a

0.67c

0.12

0.06

G-25-II

6

G-25-III
G-25-IV
G-25-V

sEtvi7
1

6

6

6

0.30c

.

All diets contained 50% autoclaved soybean meal (HRSBM);
soybean test fractions replaced part of the HRSBM. Diets were
fed for five days.
2
Growth inhibitor activity was expressed as total activity (TA)
and specific activity (SA).
3Figures in the same column followed by the same letter are not
significantly different (P>0.05) using Duncan's new multiple
range test (60).
4One
half of the soybean meal source in this diet was raw
(unheated) soybean meal (RSBM) and one half HRSBM.
5The amount recovered from extracting 100 g RSBM replaced part
of the HRSBM in a diet normally containing 100 g HRSBM.
6
The amount recovered from extracting 200 g RSBM and added to a
diet normally coµtaining 100 g HRSBM.
7Standard error of mean.
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different (P>o.05) than the pH 4.4-S diet.

Fractions III, IV and V

were not significantly different from the HRSBM diet (P>0.05).
Growth inhibition due to the fraction I diet could possibly be
attributed to trypsin inhibitors or some other proteinaseous material
with a molecular weight greater than 5,000 but less than 30,000.

This

seems to be a reasonable assumption since Schingoethe et al. (54)
found little or no.GI activity in the fraction-containing protefns
with molecular weights greater than 30,000.

However, they found

relatively the same amount of GI activity in their trypsin inhibitorcontaining fraction as was observed with fraction I.

Also,

crystalline trypsin inhibitor does not cause the extreme growth
depression found when feeding RSBM (17, 19, 21).

Fraction I had a

very high specific GI activity (860 units/g) and caused pancreatic
enlargement, 0.95% compared to 0.69°/4 for the HRSBM fed mice, when
expressed as %-body weight.

Total GI activity was divided into

fractions I and II, with fraction II containing slightly more than
half of the total GI aGtivity.

The lower specific GI activity

associated with fraction II was attributed to the extraneous material
present in this fraction.

A trace of GI activity was found in

fraction III, which may have resulted from incomplete separation from
fraction II.

Fraction IV and V did not cause growth depression or

pancreas enlargement.
The retention of the growth inhibitor located in peak II on
the Sephadex G-25 column indicated a small molecular weight material.
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Known molecular weight substances were eluted on the same Sephadex
G-25 column (previously used for the separation of the pH 4.4-S) in
an attempt to estimat'e the molecular weight of the growth inhibitor
·located in peak II.

Comparing the elution pattern of these known

molecular weight substances to the elution pattern of the pH 4.4-S
(Fig. 2), soybean trypsin inhibitor 1 (24,000 MW) eluted off the same
as peak I.

GlucagQn

2

(3,4oO MW) eluted off between peaks I and ~I,

whereas tryptophan3 (200 MW) was eluted on the declining side of
,peak III.

I

Plotting log of molecular weight versus elution volume

indicated a molecular weight of 1,200 for peak II, 500 for peak III
and molecular weights similar to those of smaller amino acids for
peaks IV and V.

The data of four mouse growth assays (see Appendix tables 1-3
for actual data), in which the various G-25 fractions were fed, are
summarized in table 3.

Growth depression was divided between fractions

I and II, with fraction I causing pancreas enlargement as compared to
the HRSBM diet.
in table 2.

Fraction III had a higher GI activity than observed

This was probably due to poor separation from fraction

II in initial column runs.
1

Although total GI activity was about the

soybean trypsin inhibitor 5 X crystallized, Nutritional Biochemical
corporation, Clevelana, Ohio.
2
Nutritional Biochemical Corporation, Cleveland, Ohio.
3Eastman Organic Chemicals, Rochester, New York.
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Table 3.

Growth Inhibitor and Pancreas Enlargement Activities of
G-25 separated fractio.ns of pH 4.4 supernatant. (See
Appendix tables 1-3 for actual data.)

Test fraction

1

Weight
gain
(g/day)

HRSBM
4

pH 4~4 - s5
G-25-I

6

G-25-II

6

G-25-III
G-25-IV
G-25-V

Growth Inhibitor
TA
SA
(units)
(units/g)

6

6

6

1
see footnote
2
see footnote
3 Pancreas wt.
Pancreas wt.
4
see footnote
5 see footnote
6See footnote

1'
2,
as
as
4,
5,
6,

Relative 3
pancreas
size

(%)

100

0.69

Y2HRSBM - Y2RSBM

I

2

-0.14

120

85

143

-0.10

114

200

131

0.23

67

913

144

0.16

77

334

106

o.45

35

170

100

0.78

. 98

0.79

101

table 2.
2.
wt. on test diet
X 100
0
~
body wt. on HRSBM
table 2.
table 2.
table 2.
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same in fractions I and II, - fraction I had a much higher specific GI
activity.

Protein fraction II had a lower specific GI activity than

fraction I because of the high carbohydrate concentration present with
the protein fraction.

Fractions IV and V showed no GI activity, and

fractions II, III, IV and V did not cause pancreas enlargement.
Growth inhibition associated with fraction I was not separated
from the trypsin inhibitors.

However, until this fraction is further

purified the growth depression may or may not be attributed to the
trypsin inhibitors.

Fraction II caused growth depression, was free of

any trypsin inhibitors and did not cause pancreatic enlargement.
Sharper separation between the trypsin inhibitors and small mol~cular
weight growth inhibitor, than that reported by Schingoethe et al. (54),
was accomplished by using the Sephadex G-25 column.

However, since

the specific GI activity attributed to this fraction was not as high
as fraction I, more purification is needed to ascertain whether the
carbohydrate material or other unidentified materials are contaminants
or a cause of the growth inhibition.

Because of the clear separation

between fractions I and II, it was concluded that these were two
different growth inhibitors.
Separation by activated charcoal.

In an attempt to separate

the carbohydrate materjal from the protein fractions, a fractionation
scheme (Fig. 1) was devised using activated charcoal as a crude ion
exchange bed.

If this system would separate the growth inhibitor from

carbohydrates or from other materials, it could be readily applied on
a commercial basis.
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After lyophilizing the various filtrates that resulted from
charcoal fractionation, they were redissolved in distilled water and
applied to t~e same Sephadex G-25 column that was used for the
pH 4.4-S separation.

This was done as a means of desalting and also

to see if any separation had been achieved by this fractionation
scheme.
Figure 3 show~ the separation of the pH 4.4-S achieved by the
activated charcoal fractionation.

In comparing figures 2 and 3,

/ peak I (Fig. 2) was located primarily in the charcoal filtrate (scan
no.. 1, Fig. 3), which also had trypsin inhibitor activity and contained
almost all of :the carbohydrate material that was recovered.
latter may be more clearly shown in table 4.

The

The pH 11.5 filtrate

(scan no. 2, Fig. 3) contained a small amount of peak I (Fig. 2) and
predominantly peaks II and III (Fig. 2).

The pH 11.5 filtrate

contained small amounts of trypsin inhibitor activity and carbohydrate
material (table 4).

Peak II (Fig. 2) was the most abundant in the

pH 8.0 filtrate (scan no. 3, Fig. 3) with no trypsin inhibitor
activity and a very small amount of carbohydrate material (table 4).
Scan 4 (Fig. 3) showed that a very minute amount of protein was
recovered in the pH 2.5 filtrate.
peak II (Fig. 2) components.

The protein present was primarily

Also, the carbohydrate concentration was

low, with no trypsin inhibitor activity (table 4) being found.
Table 4 also shows the dry matter recovered in the various
freeze dried filtrates.

Because of the added NaOH and HCl, the dry

matter recovered from all of the filtrates was higher than that
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Table

4. Carbohydrate concentration, dry matter recovered and
trypsin inhibitor activity in the various charcoal
separated pH 4. 4-S filtrates .

Filtrate

Carbohydrate
concentration

Dry Matter

1

2

Trypsin
inhibitor
ac tivity

(µg/ml)

(g )

965

21.0

+

Cha rcoal filtrate

460

6.o

+

.
4
pH 11.5 filtrate

58

12.8

+

pH 8.o filtrate

32

4.8

pH 2. 5 filtrate

22

3.0

pH

4. 4 - S3

1
Dry matter that was recovered from 100 g RSBM .
~rypsin inhibitor activity was indicated as being present(+)
or not present(-) in the various filtrates .
3This was the starting material for the charc oal fracti onation
scheme . This was analyzed to compare with the filtrates for
a~ounts recovered or lost during fractionation .
4
This filtrate showed trypsin inhibitor activity if the
filtrate was neutralized immediately to pH 7 . 0 .
Denaturation of proteins occurred if the filtrate was left
at pH 11 . 5 .
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normally recovered from the freeze dried pH 4.4-S.

Salt

concentrations in the pH 11.5 and pH 8.o filtrates were 22% and 18%,
respectively.

After desalting, both contained 11% salt.

Data of four mouse growth assays in which the charcoal filtrates
were utilized as the test diets are summarized in table 5 (see
Appendix tables 4-7 for actual data).

Although no large differences

were found between the weight gains of the mice fed the various test
diets and the HRSBM diets, the pH 8.0 filtrate had a high .GI activity
with no pancreas enlargement.

Since elution on Sephadex G-25 (Fig. 3)

indicated that the pH 8.·o filtrate contained predominantly fractions
II and III and no fraction I, growth inhibition was probably du~ to
fraction II.

However, because of the extreme pH changes, the proteins

were denatured and thus decreased the growth inhibitor activity.
Fractions II and III (pH 4.4-S separated on Sephadex G-25
column) were coliected together and lyophilized.

Thirty-five grams of

fractions II and III (amount recovered from 25 column runs) were_
redissolved in one liter of distilled water and sent through the same
fractionation scheme shown in figure 1.

The procedure was modified

slightly in t~at much weaker concentrations of base and acid were used.
Approximately 23 grams of dry matter were recovered in all of the
filtrates.
Growth trial results from feeding the various filtrates of the
charcoal fractionation of fractions II and III are shown in table 6
(see Appendix table 4 for actual data).

Growth inhibitor activity was
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Table

5. Growth assay by mice fed various fractions of pH 4.4
supernatant eluted through Charcoal .
tables 4-7 for actual 'data.)

Test fraction

1

Growth Inhibitor

TA

( units)

(See Appendix

2
SA

(units/g)

HRSBM

Relative 3
pancreas
size

(%)

100

1/2.HRSBM - 1/2RSBM

4

120

85

143

114

201

131

19

33

104

6

7

98

pH 8. 0 filtrate

25

350

97

6
pH 2. 5 filtrate

18

122

93

pH 4. 4 - S5
Cha rcoal filtrate
pH 11.5 filtrate

6

6

:6

1

2see
see
3see
4
see
5see
6See

footnote
footnote
footnote
footnote
footnote
footnote

1'
2,
3,
4,
5,
6,

table
table
table
table
table
table

2.
2.
3.
2.
2.
2.
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:':,t,l c

~:et

6.

Growth assay by mice fed various fractions of G-25
Fraction II and III eluted through Charcoal. (See
Appendix table 4 for actual data.)

1

Growth Inhibitor

TA

(units)

2

SA

(units/g)

Relative 3
pancreas
size

(%)

100

~:RSBM - 1/2RSBM
-:J

4.4

4

s

120

143

114

201

131

Charcoal filtrate 5

17

39

96

pH 11.5 filtrate 5

23

230

pH 8.0 f:i.ltrate 5

27

:-25 Fraction II and III

pH 2.5 filtrate 5

92
104

1 2
, See footnotes 1 and 2, table 2.
3see footnote 3, table 3.

4see footnote 5, table 1.
5The amount r ecovered f r om 35 g, freeze

dried fractions II and
III, sent through charcoal fractionation.
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again located in the pH
in table 5.

8.0 filtrate, substantiating results reported

The pH 11.5 filtrate contained the second highest GI

activity with none of the filtrates causing pancreas enlargement.
Although the small molecular weight growth inhibitor was in
fractions II and III prior to sending it through the charcoal, very
little of the growth depressant was recovered in the charcoal
filtrates.

Absence of the growth depression was attributed to the

extreme pH changes, which caused denaturation of proteins. ·
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SUMMARY AND CONCLUSIONS
Ion exclusion chromatography was employed to further purify and
separate a small molecular weight growth inhibitor from soybean
trypsin inhibitors.

The pH 4.4-S was separated on a Sephadex G-25

column into five fractions.

Fraction I contained proteinaceous

material greater than 5,000 molecular weight and trypsin inhibitor
activity.

Diets containing this fraction when fed to mice caused

growth depression and pancreas enlargement.

Growth depression was

caused by fraction II diets, but no pancreas enlargement was noticed.
The growth inhibitor present in fraction II was calculated to have a
molecular weight of 1,200.

The diets containing G-25 fractions III,

IV and V caused little or no growth depression to mice and did not
cause pancreas enlargement.

Because of the clear separation

accomplished between fractions I and II, with both causing growth
depression and only fraction I causing pancreas enlargement, it was
concluded that these are two different growth inhibitors present in
the soybean whey fraction.

The mechanism of the growth inhibition by

these inhibitors may be different.
Animal growth assays are the only positive measurement of the
growth depressant in soybeans.

However, this method involves a great

deal of time in preparation of the fractions to be used in the diets.
An attempt was made to batch separate the growth inhibitor from
so~beans, utilizing activated charcoal as a crude ion exchange bed.

In comparing this fractionation to the separation via the
Sephadex G-25 column, preferential separation was achieved.

However,

the extreme pH changes employed, denatured the proteins and decreased
the growth inhibitor (GI) activity of the various filtrates.
Elimination of some of the carbohydrate material as the cause of the
growth depression was accomplished by this fractionation.

The pH 8.0

filtrate had the highest GI activity of the various filtrates in most
of the mouse growth assays.

There are three possible explanations

for this, and they are:
1)

Greater denaturation occurred at the pH extremes.

2)

G-25 peak II was the most prevalent in the pH 8.0 filtrate.

3)

The growth inhibitor may be active at pH 8.o and inactive
at extreme pH's.

The pH 8.0 filtrate caused growth inhibition even though it was almost
void of G-25 pea~ I.

However, it was concluded that because of the

denaturation of proteins incurred during the fractionation, this
method would possibly be better suited to detoxify the soybean whey
fraction than to separate and purify the growth inhibitor.
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Appendix Table I.

Test fraction

1

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed to mice. (Mouse growth assay No. 1.
Diets fed for five days.)
Weight
gain

Pancreas size

(g/day)

(g)

o.78a, 3

HRSBM
1/2.HRSBM - 1/2RSBM

pH 4._4 - S
G-25 -

r4

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g/day) (g/100 g diet)

0.11

0.57c

4.8

50.0

:...0.43c

0.14

0.92a

2.5

25~0

o.43b

0.14

0.77b

4.4

7.0

0.78a

0.13

o.6$b

4.9

0.3

G-25 - II

&

III

o.56ab

0.11

o.64b

4.8

4.o

G-25

&

V

0.71a

0.12

o.63bc

4.9

0. ,1

IV

SEM5

0.09
1

0.04

see text for complete description of test fractions.
2iest fraction is equivalent to the quantity recovered from
100 g RSBM except for HRSBM, 1/2HRSBM - 1/2RSBM.
3Figures in the same column followed by the same letter are not
significantly different (P>0.05) using Duncan's new multiple
range test (60).
4
This fraction was concentrated in a Virtis freeze concentrator
and probably denatured the proteins. (Only for this trial.)
5 Standard error of mean. -

•.
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Appendix Table It.

Test fraction

1

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed to ·mice. (Mouse growth assay No. 2.
Diets fed for three days.)
Weight
gain

Pancreas size

(g,/da:y)

(g)

0.30a,3

HRSBM

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g,/day) (g/100 g diet)

0.15

o.69bc

7.4

50.0

1/:iliRSBM - 1/2RSBM

-0.66cd

0.16

o.83ab

5.1

25.0

pH 4.4 - S

-0.91d

0.16

o.84a

7.3

10.0

• 0.19

0.94a

6.3

1.5

0.15

o.69bc

5.4

3.8

0.14

0.67C

7.3

5.7

IG-25 - I
G-25 - II
G-25 - III
SEM

4

-0.36bc
-0.27b
o.07ab
0.09

0.04

1 see footnote 1 Appendix Table I.
~est fraction is equivalent to 2 X the quantity recovered from
1~0 g RSBM except HRSBM, 1/zHRSBM - 1/2.RSBM, and pH 4.4.
3 ' See footnotes 3 and 5 Appendix Table I •

•.
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Appendix Table III.

Test fraction

1

HRSBM
1/.iliRSBM - 1/2.RSBM

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed tb mice. (Mouse growth assay No. 3.
Diets fed for five days.)
Weight
gain

Pancreas size

(g,lday)

(g)

o.74a, 3
.
b
-0.18

0.10

0.59c

7.25

50.0

0.14

0.97a

4.8

25.b

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g/day) (g/100 g diet)

G-25 -

I

0.50a

0.14

o.93ab

4.o

1.6

G-25 -

II

o.46a

0.10

0.65c

4.6

3-9

G-25 - III

0.50a

0.11

o.68bc

5-5

3-5

SEM

0.09

4

0.09

~See footnote 1 Appendix Table I.
s~e footnote 2 Appendix Table II.
3 'See footnotes 3 and 5 Appendix Table I.
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Appendix Table IV.

Test fraction

1

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed to -mice. (Mouse growth assay No. 4.
Diets fed for five days.)
Weight
gain

Pancreas size

(g/day)

(g)

o.75a, 3

HRSBM

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g/day) (g/100 g diet)

0.11

o.66c

6.3

50.0

1/2HRSBM - 1/2.RSBM

.
C
-0.21

0.1 6

0.92a

5.6

25.b

pH 4.4 - S

-o.48c

0.12

o.88ab

3.5

10.0

0.37a, b • 0.13

5.6

2.5

0.24b

4.5

8.8

2.2

12.8-

_I G-25 - I
Charcoal filtrate

: 4

pH 11.5 filtrate

-1.12

0.11

d

pH 8.0 filtrate

0.03bc

0.09

o.64c

4.6

5.2

pH 2.5 filtrate

0.51a

0.11

0.61d

6.2

2.9

Charcoal G-25
II & III filtrate

0.63a

0.10

5.6

6.8

pH 11.5 G-25
II & III filtrate

0.58a

0.09

5.5

1.6

pH 8.0 G-25
II & III filtrate

0.54a

0.11

6.3

o.8

pH 2.5 G-25
II & III filtrate

0.79a

0.11

5.6

0.3

0.15
1

0.67c
0.04

see footnote 1 Appendix Table I.
See footnote 2 Appendix Table II.
'See footnote 3 Appendix Table I.
Mice died before termination of experiment so three day weights
were used and pancreases were not weighed. Death may be
attribut-ed to high salt concentration.
5 See footnote 5 Appendix Table I.
2
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Appendix Table V.

Test fraction

1

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed to mice. (Mouse growth assay No. 5.
Diets fed for five days.)
Weight
gain

Pancreas size

(g/day)

(g)

o.61a, 3

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g/day) (g/100 g diet)

0.09

o.67ab

5.4

50.0

b

0.10

o.86a

3.8

25.0

pH 4.4 - S

0.17b

0.10

0.81a

2.7

10.0

Charcoal filtrate

o.68a

0.11

0.75a

3-5

6.4

4

0.65a

0.09

0.61b

5.7

2.4

4

o.6oa

0.09

0.61b

3.9

o.4_

HRSBM, pair fed 5

0.57a

0.09

0.59b

3-5

50.0

HRSBM
1/2.HRSBM - 1/zRSBM

-0.07

pH 11.5 filtrate
pH 8.o filtrat~

sni

0.12

0.06

1
see footnote 1 Appendix Table I.
2 See footnote 2 Appendix Table II.
'See footnote_ 3 Appendix Table I.
NH40H used instead of NaOH and also at a weaker concentration.
~Fed HRSBM equal to the charcoal filtrate diet.
See footnote 5 Appendix Table I.
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Appendix Table VI.

Test fraction

1

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed to mice. (Mouse growth assay No. 6.
Diets fed for five days.)
Weight
gain

Pancreas size

(g/day)

(g)

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g/day) (g/100 g diet)

HRSBM

o.98a, 3

0.10

0.56b

4.9

50.0

1/iHRSBM - 1/2RSBM

0.29cd

0.15

0.92a

4.o

. 25.0

0.54c

0.14

0.85a

4.9

·B.o

o.46c

0.08

0.52b

4.6

10.8

pH 4.4

s4

Charcoal filtrate 5
.
6
pH 11.5 filtrate
pH 8.o filtrate

4.o

6

4.4

pH 11.5 filtrate 7

1.19a

0.11

0.63b

4.4

1.3

pH 8.0 filtrate?

o.86ab

0.09

0.57b

4.6

0.3

0.99a

0.10

0.54b

4.3

2.1

0.94a

0.82

0.53b

3.8

0.3

o.61bc

0.09

0.58b

4.4

6.o

0.15d

0.07

0.53b

4.4

12.0

pH 11.5 filtrate
pH 8.0 filtrate
15 . g Nac1 9
';I)

g Nac1 9

SEM10

8

8

0.09

1

0.04

See footnote 1 Appendix Table I.
See footnote 2 Appendix Table II.
~See footnote 3 Appendix Table I.
Diet was made up to 250 g instead of the usual 200 gin an.
attempt and may be reason for higher gain/day.
~Added to diet 5 X the normal rate recovered from 100 g RSBM.
Ba(0H) • 8H o and ZnS0 used as basic and acidic reagents.
2
4
2
~ice died of zinc toxicity.
Ba(0H) • 8H o and H so used as basic and acidic reagents.
2 4
8
2
2
Na0H concentration was much weaker than used previously.
9This was a higher level of salt than was present in pH 11.5 and
pH 8.0 filtrates, mouse growth assay No. 4 (Appendix Table IV).
10
See footnote 5 Appendix Table I.
2
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Appendix Table VII.

Test fraction

1

Individual weight gains, pancreas size, feed
intake and quantity of test fraction in various
diets fed to ·mice. (Mouse growth assay No. 7.
Diets fed for five days.)
Weight
gain

Pancreas size

(g/day)

(g)

(%

Feed
intake

Test
2
fraction
in diet
body wt) (g/day) (g/100 g diet)

HRSBM

1.11a, 3

0.11

0.55c

4.8

50.0

1/MRSBM - 1/zRSBM

0.30b

0.16

0.95a

4.o

25.b

pH 4.4 - S

0.22b

0.12

0.81b

4.2

10.0

Charcoal filtrate

0.85a

0.10

0.52

5-5

7.4

4

o.86a

0.12

o.61c

4.8

6.4

pH 8 .O filtrate

0.97a

0.11

o.6oc

5-3

4.o -

pH 11.5 filtrate 5

1.ooa

0.09

0.51c

4.5

4.5

pH 8.0 filtrate 5

1.02a

0.10

0.53c

5-5

2.5

pH 11.5 filtrate

:4

15 g NaC1

30 g NaC1
SEM 7

C

6

0.81a

4.8

6.o

6

0.10b

4.6

12.0

0.11

0.04

1
see footnote 1 Appendix Table I.
2 See footnote 2 Appendix Table II.
lsee footnote 3 Appendix Table I.
Test fraction fed is half as much as fed in mouse growth assa:y
No. 4 (Appendix Table IV). Not desalted.
5Test fraction fed is half as much as fed in mouse growth assay
No. 4 (Appendix Table IV). Desalted by eluting through Sephadex
G-25 column.
6Pancreases we r e n ot weighed because in a previous trial (Appendix
Table VI), the pancreases had not been affected by the high salt
concentration.
7See footnote 5 Appendix Table I.

